Aehr Test Systems Form 4 insider transactions
NASDAQ
Form 4: Gayn Erickson Files SEC Form 4
Gayn Erickson, President and CEO of AEHR TEST SYSTEMS, reported transactions involving company stock, including the acquisition of shares upon vesting of performance-based RSUs and the withholding of shares for tax obligations.
NASDAQ
A Form 4 filing reveals stock transactions by Adil Engineer, Chief Operating Officer of Aehr Test Systems, involving the issuance and withholding of common stock.
NASDAQ
AEHR TEST SYSTEMS reports a Form 4 filing detailing stock transactions by Director Fariba Danesh, including vesting of restricted stock units.
NASDAQ
Aehr Test Systems Director Geoffrey G. Scott has reported transactions involving company stock, including the acquisition of restricted stock units.
NASDAQ
Aehr Test Systems Director Laura Oliphant has reported transactions involving restricted stock units, with a portion vesting on July 1, 2026.
NASDAQ
Howard T. Slayen, a Director at Aehr Test Systems, reported the vesting of restricted stock units and updated beneficial ownership.
NASDAQ
Rhea J. Posedel, a Director at AEHR Test Systems, has filed a Form 4 detailing transactions related to her beneficial ownership of company stock.
NASDAQ
Didier Wimmers, Executive VP of R&D at Aehr Test Systems, reported a transaction involving the withholding of shares for tax obligations.
NASDAQ
CFO Chris Siu of Aehr Test Systems reported the withholding of 350 shares to satisfy tax obligations related to restricted stock unit vesting.
NASDAQ
Aehr Test Systems director Howard T. Slayen sold 6,819 shares of common stock on May 13, 2026.
NASDAQ
CFO Chris Siu sold a total of 2,070 shares of Aehr Test Systems common stock on May 14, 2026.
NASDAQ
Aehr Test Systems files an amendment to a Form 4, correcting a transaction code related to beneficial ownership of common stock.
NASDAQ
Alberto Salamone, EVP of Aehr Test Systems, reported the withholding of 204 shares to cover tax obligations related to restricted stock unit vesting.
NASDAQ
AEHR TEST SYSTEMS reports a Form 4 filing by Director Geoffrey G. Scott detailing transactions in company stock, including a donation to a charitable fund.
NASDAQ
Alistair N. Sporck, VP of Contactor Business Unit at Aehr Test Systems, had 133 shares withheld for tax purposes following RSU vesting.
NASDAQ
Executive VP Vernon Rogers had 139 shares withheld to cover tax obligations following the vesting of restricted stock units.
NASDAQ
Chief Technology Officer Donald P. Richmond II saw 102 shares withheld to cover tax liabilities following the vesting of restricted stock units.
NASDAQ
CEO Gayn Erickson reported the withholding of 851 shares to satisfy tax obligations related to the vesting of restricted stock units.
NASDAQ
Chief Operating Officer Adil Engineer reported a routine withholding of 143 shares to satisfy tax obligations upon the vesting of restricted stock units.
NASDAQ
Director Rhea J. Posedel reported the sale of 17,719 shares of Aehr Test Systems common stock on April 22, 2026.
NASDAQ
Alistair N. Sporck, VP of a Business Unit at Aehr Test Systems, sold 2,000 shares of common stock on April 22, 2026.
NASDAQ
Aehr Test Systems EVP Alberto Salamone sold 30,000 shares of common stock over two days in April 2026.
NASDAQ
Director Howard T. Slayen reported a charitable donation of 1,800 shares of Aehr Test Systems common stock.
NASDAQ
Director Geoffrey G. Scott reported the sale of 60,000 shares of Aehr Test Systems common stock on April 21, 2026.
NASDAQ
Vernon Rogers, Executive VP of Sales & Marketing at Aehr Test Systems, sold 5,000 shares of common stock at $90 per share.
NASDAQ
Director Rhea J. Posedel sold 8,787 shares of Aehr Test Systems common stock at an average price of $96.0233.
NASDAQ
Vernon Rogers, Executive VP of Sales & Marketing at Aehr Test Systems, sold 6,486 shares of common stock.
NASDAQ
Alistair N. Sporck, VP of Aehr Test Systems, reported the withholding of 341 shares to satisfy tax obligations upon the vesting of restricted stock units.
NASDAQ
Vernon Rogers, Executive VP of Sales & Marketing at Aehr Test Systems, sold 2,431 shares of common stock.
NASDAQ
Director Rhea J. Posedel sold 7,500 shares of Aehr Test Systems common stock on April 20, 2026.